Stan Smith, Director at MAIA Biotechnology, Inc. (MAIA), bought 7,103 shares at $4.43 ($31K) on 2023-03-03, disclosed to the SEC on 2023-03-07.
Scheduled purchase ($31k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.43 | 2,509 | $11K | 35.5% |
| 2 | $4.39 | 4,594 | $20K | 64.5% |
| Total | $4.40 avg | 7,103 | $31K | 100% |
| Filing → |
| MAIA | BUY | 2025-12-23 | $140K | — | Filing → |
| MAIA | BUY | 2025-12-09 | $11K | — | Filing → |
| MAIA | BUY | 2025-12-01 | $16K | — | Filing → |